Discovery of biphenylketones as dual modulators of inflammation and bone loss

https://doi.org/10.1016/j.bmcl.2010.07.055Get rights and content

Abstract

Biphenylketones were identified as novel inhibitors of NFκB activation. Structure–activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC50 = 0.8 μM), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo.

References and notes (11)

  • A.I. Idris et al.

    Biochem. Biophys. Res. Commun.

    (2008)
  • J.S. Smolen et al.

    Nat. Rev. Drug Disc.

    (2003)
  • I.R. Greig et al.

    J. Med. Chem.

    (2006)
  • R.J. van‘t Hof et al.

    J. Bone Miner. Res.

    (2004)
  • van‘t Hof, R. J. Unpublished...
There are more references available in the full text version of this article.

Cited by (3)

View full text